Last $9.83 USD
Change Today -0.06 / -0.61%
Volume 610.3K
SZYM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 07/21/14 All times are local (Market data is delayed by at least 15 minutes).

solazyme inc (SZYM) Snapshot

Open
$9.78
Previous Close
$9.89
Day High
$9.88
Day Low
$9.66
52 Week High
03/12/14 - $15.00
52 Week Low
11/25/13 - $8.00
Market Cap
746.8M
Average Volume 10 Days
820.6K
EPS TTM
$-1.82
Shares Outstanding
76.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SOLAZYME INC (SZYM)

solazyme inc (SZYM) Related Businessweek News

View More BusinessWeek News

solazyme inc (SZYM) Details

Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts. The company offers renewable tailored oils, such as oleic oils that provide sustainable solutions within the food, lubricant, functional fluid, and oleo chemical markets; and drop-in replacements and blend stocks for marine, motor vehicle and jet fuels, as well as replacements for petrochemicals. It is also provides fuels, including SoladieselBD, a fatty acid methyl ester; SoladieselRD, a hydro-treated renewable diesel; SoladieselHRD-76, a military grade hydrotreated renewable diesel; and SolajetD7566 and SolajetHRJ-5 that are commercial and military grade hydrotreated renewable jets. In addition, the company offers microalgae-based food ingredients consisting of tailored oils and whole algal powders that enhance the nutritional profile and functionality of food products; and powdered ingredients comprising whole algal flour, whole algal protein, and golden chlorella high protein. Additionally, it provides skin and personal care products under the Algenist brand name, which include concentrated reconstructing serum, an anti-aging serum; complete eye renewal balm; firming and lifting cream, an anti-aging moisturizing cream; advanced anti-aging repairing oil, a face oil formulation; and genius cream. The company was incorporated in 2003 and is headquartered in South San Francisco, California.

271 Employees
Last Reported Date: 03/14/14
Founded in 2003

solazyme inc (SZYM) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $545.0K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $360.7K
Chief Technology Officer
Total Annual Compensation: $360.7K
Corporate Secretary and General Counsel
Total Annual Compensation: $321.4K
Strategic Advisor
Total Annual Compensation: $412.0K
Compensation as of Fiscal Year 2013.

solazyme inc (SZYM) Key Developments

Solazyme, Inc. Appoints Tyler W. Painter as it's Chief Operating Officer

Solazyme, Inc. announced that on July 1, 2014, the company appointed Tyler W. Painter as it's chief operating officer (in addition to his current role as chief financial officer), effective immediately.

Solazyme, Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014

Solazyme, Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.

Solazyme, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides CapEx Guidance for the Year 2014

Solazyme, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported total revenue of $12.4 million compared with $6.7 million in the first quarter of 2013, an increase of 85%. Loss from operations was $32,441,000 against $23,360,000 a year ago. Net loss was $34,681,000 or $0.50 per basic and diluted share against $26,525,000 or $0.43 per basic and diluted share a year ago. Net loss (non-GAAP) was $30,528,000 or $0.44 per basic and diluted share against $21,502,000 or $0.35 per basic and diluted share a year ago. Net cash burned in the first quarter was $34 million, including an $8 million equity investment in Solazyme Bunge renewable oils joint venture in Brazil, $2.5 million in interest payments and working capital investments related to Encapso and fuels projects. With the current projects on hand, the company remain on track where total CapEx, including equity investments in SB oils, to be approximately $40 million for the year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SZYM:US $9.83 USD -0.06

SZYM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Amyris Inc $3.62 USD +0.03
Gevo Inc $0.72 USD -0.0409
Pacific Ethanol Inc $18.13 USD +0.34
Renewable Energy Group Inc $11.03 USD +0.02
View Industry Companies
 

Industry Analysis

SZYM

Industry Average

Valuation SZYM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 15.1x
Price/Book 5.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLAZYME INC, please visit www.solazyme.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.